Literature DB >> 31958408

Constitutive activity of 5-HT receptors: Factual analysis.

Philippe De Deurwaerdère1, Rahul Bharatiya2, Abdeslam Chagraoui3, Giuseppe Di Giovanni4.   

Abstract

The constitutive activity of different serotonin receptors (5-HTRs) toward intracellular signaling pathways has been proposed to have physiological and pathological importance. Inverse agonists block the constitutive activity and can be used to probe and silence such a spontaneous activity. The constitutive activity of 5-HTRs can be observed in various heterologous systems of expression in vitro (very high for 5-HT2CR; very low for 5-HT2AR). The demonstration of the existence of this activity in native tissues and ultimately in integrative neurobiology and behavior is a real pharmacological challenge. Irrespective of the existence of mutants or polymorphisms that could alter the constitutive activity of 5-HTRs, evidence suggests that spontaneous activity of 5-HT2CR could impact the activity of neurobiological networks and that of 5-HT6R and 5-HT7R the developmental morphogenesis. Some findings exist for 5-HT2BR and 5-HT2AR in diverse though rare conditions. The existence of a constitutive activity for 5-HT1AR, 5-HT1B/1DR, and 5-HT4R is still poorly supported. When identified, the constitutive activity may differ according to brain location, state of activity (phasic in nature), and intracellular signaling pathways. A very few studies have reported aberrant constitutive activity of 5-HTRs in animal models of human diseases and patients. The purpose of this review is a critical examination of the available neuropharmacological data on the constitutive activity of 5-HTRs to determine whether this activity is an essential component of the serotonergic system transmission and it may be a possible target for CNS drug development.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antagonist; Biased agonist; Dopamine; G-protein; Inverse agonist; Learning; Spasticity

Mesh:

Substances:

Year:  2020        PMID: 31958408     DOI: 10.1016/j.neuropharm.2020.107967

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  11 in total

1.  Is the 5-hydroxytryptamine 7 Receptor Constitutively Active in the Vasculature? A Study in Veins/Vein.

Authors:  Stephanie W Watts; Emma D Flood; Janice M Thompson
Journal:  J Cardiovasc Pharmacol       Date:  2022-08-01       Impact factor: 3.271

2.  Expression of the Human Serotonin 5-HT7 Receptor Rescues Phenotype Profile and Restores Dysregulated Biomarkers in a Drosophila melanogaster Glioma Model.

Authors:  Florestan Courant; Marion Maravat; Wanyin Chen; David Gosset; Lauren Blot; Nadège Hervouet-Coste; Vincent Sarou-Kanian; Séverine Morisset-Lopez; Martine Decoville
Journal:  Cells       Date:  2022-04-09       Impact factor: 7.666

3.  Structural insights into the lipid and ligand regulation of serotonin receptors.

Authors:  Peiyu Xu; Sijie Huang; Huibing Zhang; Chunyou Mao; X Edward Zhou; Xi Cheng; Icaro A Simon; Dan-Dan Shen; Hsin-Yung Yen; Carol V Robinson; Kasper Harpsøe; Bo Svensson; Jia Guo; Hualiang Jiang; David E Gloriam; Karsten Melcher; Yi Jiang; Yan Zhang; H Eric Xu
Journal:  Nature       Date:  2021-03-24       Impact factor: 49.962

4.  5-HT6R null mutatrion induces synaptic and cognitive defects.

Authors:  Zehui Sun; Bingjie Wang; Chen Chen; Chenjian Li; Yan Zhang
Journal:  Aging Cell       Date:  2021-05-07       Impact factor: 9.304

5.  The Antagonism of 5-HT6 Receptor Attenuates Current-Induced Spikes and Improves Long-Term Potentiation via the Regulation of M-Currents in a Pilocarpine-Induced Epilepsy Model.

Authors:  Chaofeng Zhu; Rong Lin; Changyun Liu; Mingzhu Huang; Feng Lin; Gan Zhang; Yuying Zhang; Junjie Miao; Wanhui Lin; Huapin Huang
Journal:  Front Pharmacol       Date:  2020-04-28       Impact factor: 5.810

6.  2-Phenyl-1H-pyrrole-3-carboxamide as a New Scaffold for Developing 5-HT6 Receptor Inverse Agonists with Cognition-Enhancing Activity.

Authors:  Marcin Drop; Vittorio Canale; Séverine Chaumont-Dubel; Rafał Kurczab; Grzegorz Satała; Xavier Bantreil; Maria Walczak; Paulina Koczurkiewicz-Adamczyk; Gniewomir Latacz; Anna Gwizdak; Martyna Krawczyk; Joanna Gołębiowska; Katarzyna Grychowska; Andrzej J Bojarski; Agnieszka Nikiforuk; Gilles Subra; Jean Martinez; Maciej Pawłowski; Piotr Popik; Philippe Marin; Frédéric Lamaty; Paweł Zajdel
Journal:  ACS Chem Neurosci       Date:  2021-03-11       Impact factor: 4.418

Review 7.  Potential Roles of Enterochromaffin Cells in Early Life Stress-Induced Irritable Bowel Syndrome.

Authors:  Enfu Tao; Zhenya Zhu; Chenmin Hu; Gao Long; Bo Chen; Rui Guo; Marong Fang; Mizu Jiang
Journal:  Front Cell Neurosci       Date:  2022-03-15       Impact factor: 5.505

8.  Aripiprazole Offsets Mutant ATXN3-Induced Motor Dysfunction by Targeting Dopamine D2 and Serotonin 1A and 2A Receptors in C. elegans.

Authors:  Ana Jalles; Cármen Vieira; Joana Pereira-Sousa; Daniela Vilasboas-Campos; Ana Francisca Mota; Sara Vasconcelos; Bruna Ferreira-Lomba; Marta Daniela Costa; Jorge Diogo Da Silva; Patrícia Maciel; Andreia Teixeira-Castro
Journal:  Biomedicines       Date:  2022-02-03

9.  Novel N-Arylsulfonylindoles Targeted as Ligands of the 5-HT6 Receptor. Insights on the Influence of C-5 Substitution on Ligand Affinity.

Authors:  Loreto Arrieta-Rodríguez; Daniela Espinoza-Rosales; Gonzalo Vera; Young Hwa Cho; David Cabezas; David Vásquez-Velásquez; Jaime Mella-Raipán; Carlos F Lagos; Gonzalo Recabarren-Gajardo
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-01

10.  HTR1A, HTR1B, HTR2A, HTR2C and HTR6 Gene Polymorphisms and Extrapyramidal Side Effects in Haloperidol-Treated Patients with Schizophrenia.

Authors:  Mirko Grubor; Maja Zivkovic; Marina Sagud; Matea Nikolac Perkovic; Alma Mihaljevic-Peles; Nela Pivac; Dorotea Muck-Seler; Dubravka Svob Strac
Journal:  Int J Mol Sci       Date:  2020-03-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.